IRIS
MARZIONI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.469
EU - Europa 4.817
AS - Asia 4.194
SA - Sud America 1.104
Continente sconosciuto - Info sul continente non disponibili 464
AF - Africa 217
OC - Oceania 7
Totale 22.272
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.265
SG - Singapore 1.318
VN - Vietnam 945
BR - Brasile 851
RU - Federazione Russa 841
IT - Italia 790
CN - Cina 679
UA - Ucraina 669
IE - Irlanda 444
DE - Germania 415
SE - Svezia 402
HK - Hong Kong 369
FR - Francia 322
GB - Regno Unito 227
DK - Danimarca 223
FI - Finlandia 217
TR - Turchia 203
BD - Bangladesh 141
KR - Corea 117
IN - India 115
CA - Canada 101
AR - Argentina 79
CI - Costa d'Avorio 59
MA - Marocco 59
NL - Olanda 54
ES - Italia 51
PL - Polonia 50
MX - Messico 47
EC - Ecuador 46
IQ - Iraq 46
JP - Giappone 45
ID - Indonesia 43
ZA - Sudafrica 42
CO - Colombia 38
PY - Paraguay 25
VE - Venezuela 25
BE - Belgio 24
AT - Austria 21
PK - Pakistan 20
UZ - Uzbekistan 20
PH - Filippine 19
CL - Cile 17
TN - Tunisia 16
SA - Arabia Saudita 13
CR - Costa Rica 12
JO - Giordania 12
TH - Thailandia 12
LT - Lituania 10
PE - Perù 10
RO - Romania 10
UY - Uruguay 10
AZ - Azerbaigian 9
DZ - Algeria 8
EG - Egitto 8
HN - Honduras 8
IL - Israele 8
RS - Serbia 8
AE - Emirati Arabi Uniti 7
ET - Etiopia 6
EU - Europa 6
JM - Giamaica 6
KE - Kenya 6
LB - Libano 6
TW - Taiwan 6
IR - Iran 5
MY - Malesia 5
NI - Nicaragua 5
TT - Trinidad e Tobago 5
AO - Angola 4
BY - Bielorussia 4
CH - Svizzera 4
GT - Guatemala 4
PR - Porto Rico 4
PS - Palestinian Territory 4
AL - Albania 3
AU - Australia 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
KZ - Kazakistan 3
LV - Lettonia 3
MN - Mongolia 3
NP - Nepal 3
OM - Oman 3
SN - Senegal 3
BG - Bulgaria 2
BO - Bolivia 2
CY - Cipro 2
EE - Estonia 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
HR - Croazia 2
KG - Kirghizistan 2
LY - Libia 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
Totale 21.790
Salva come PNG Salva come JPEG
Città #
Ashburn 1.660
Chandler 764
Singapore 756
Jacksonville 698
Dallas 672
Fairfield 592
Council Bluffs 506
San Jose 500
Dublin 443
Des Moines 430
Boardman 399
Hong Kong 350
New York 292
Ho Chi Minh City 287
Wilmington 280
Woodbridge 279
Houston 270
The Dalles 235
Seattle 231
Hanoi 230
Los Angeles 217
Cambridge 207
Centro 202
Lauterbourg 170
Princeton 162
Lawrence 161
San Mateo 148
Moscow 129
Beijing 126
Ann Arbor 124
San Diego 85
Hefei 83
Munich 77
Buffalo 75
Chicago 75
Orem 71
Santa Clara 71
Milan 69
São Paulo 69
Helsinki 66
Washington 63
Abidjan 59
London 57
Da Nang 51
Haiphong 46
Turku 41
Warsaw 40
Montreal 38
Denver 37
Phoenix 37
Guangzhou 36
Brooklyn 35
Rio de Janeiro 34
Shanghai 33
Turin 32
Ancona 31
Tokyo 31
Nuremberg 30
Rome 27
Chennai 26
Johannesburg 26
Atlanta 25
Wuhan 23
Baghdad 22
Salt Lake City 22
Columbus 21
Toronto 20
Hải Dương 19
Miano 19
Pune 19
Brussels 18
Frankfurt am Main 18
Guayaquil 18
San Francisco 18
Stockholm 18
Ankara 17
Norwalk 17
Poplar 17
Manchester 16
Marche 16
Mexico City 16
Tashkent 16
Boston 14
Brasília 14
City of London 14
Elk Grove Village 14
Porto Alegre 14
Thái Nguyên 14
Wuxi 14
Salvador 13
Tampa 13
Belo Horizonte 12
Bắc Ninh 12
Can Tho 12
Jiaxing 12
Salamanca 12
Curitiba 11
Dhaka 11
Quito 11
Quận Ba 11
Totale 13.694
Salva come PNG Salva come JPEG
Nome #
EASL Clinical Practice Guidelines on the management of extrahepatic cholangiocarcinoma 264
Use of nailfold capillaroscopy for the early diagnosis of systemic sclerosis in patients with primary biliary cholangitis 222
Prevalence and clinical outcome of hepatic haemangioma with specific reference to the risk of rupture: a large retrospective cross-sectional study. 207
Ageing-related expression of Twinfilin-1 regulates cholangiocyte biological response to injury 196
A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury 195
HDL cholesterol protects from liver injury in mice with intestinal specific LXRα activation 186
Farnesoid X Receptor, Bile Acid Metabolism, and Gut Microbiota 181
Bile acid feeding increased proliferative activity and apical bile acid transporter expression in both small and large rat cholangiocytes 173
An oestrogen receptor β-selective agonist exerts anti-neoplastic effects in experimental intrahepatic cholangiocarcinoma. 172
H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMP-dependent PKA/ERK1/2/ELK-1 pathway. 171
Activation of the developmental pathway neurogenin-3/microRNA-7a regulates cholangiocyte proliferation in response to injury. 171
Nlrp3 Activation Induces Il-18 Synthesis and Affects the Epithelial Barrier Function in Reactive Cholangiocytes 171
Exendin-4 restores ppar-alpha and ppar-gamma activity in nash and reduces insulin resistance, pro-inflammatory mediators and total fatty acid content 170
Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD. 169
Aging and the Biological Response to Liver Injury 169
Endogenous opioids modulate the growth of the biliary tree in the course of cholestasis 165
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 159
HCC development is associated to peripheral insulin resistance in a mouse model of NASH 157
Shear wave elastography and transient elastography in HCV patients after direct-acting antivirals 157
Endoplasmic Reticulum stress induces hepatic stellate cell apoptosis and contributes to fibrosis resolution 156
Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. 153
Descriptive epidemiology of cholangiocarcinoma in Italy. 153
Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition. 153
Aging-Related Molecular Pathways in Chronic Cholestatic Conditions 153
Bullous pemphigoid of Lever and celiac disease: a coincidental occurrence or an unusual association? 151
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) 150
Leptin enhances cholangiocarcinoma cell growth. 149
Gut-Liver Axis and Inflammasome Activation in Cholangiocyte Pathophysiology 149
Clinical implications of novel aspects of biliary pathophysiology. 148
Research Strands in Dermatology and Gastroenterology Units of Department of Clinical and Molecular Sciences in Polytechnic Marche University 146
SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma 146
Functional and Structural Features of Cholangiocytes in Health and Disease 146
Bile acid depletion and repletion regulate cholangiocyte proliferation and secretion in bile duct ligated rats through a phosphatidylinositol 3-kinase-dependent pathway. 145
Exendin-4, a Glucagon-Like Peptide 1 receptor agonist, protects cholangiocytes from apoptosis 145
Hepatitis E in a region of Italy: An emerging autochthonous infection? 145
Exendin-4, a glucagon-like protein-1 receptor agonist, reduces proinflammatory conditions, and increases lipid oxidation and insulin sensitivity in hepatocytes from nonalcoholic steatohepatitis rats 144
Administration of r-VEGF-A prevents hepatic artery ligation induced bile duct damage in bile duct ligated rats. 144
Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice 143
Cholangiocarcinoma development: the resurgence of bile acids 143
Cholangiocarcinoma 2020: the next horizon in mechanisms and management 143
CAMP STIMULATES THE SECRETORY AND PROLIFERATIVE CAPACITY OF THE RAT BILIARY EPITHELIUM THROUGH CHANGES IN THE PKA/SRC/MEK/ERK1/2 PATHWAY 142
cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ERK1/2 pathway 142
Current targets for Primary Sclerosing cholangitis 141
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 141
Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies 137
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 137
Increased local dopamine secretion has growth promoting effects in cholangiocarcinoma. 136
PDX-1 mRNA expression in endoscopic ultrasound-guided fine needle cytoaspirate: Perspectives in the diagnosis of pancreatic cancer 136
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis 136
Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic Acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts 135
Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology 135
Vascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanism. 134
Current and novel therapeutic opportunities for systemic therapy in biliary cancer 134
Pancreatic Duodenal Homeobox-1 de novo expression drives cholangiocyte neuroendocrine-like transdifferentiation. 133
Gastrin reverses established cholangiocyte proliferation and enhanced secretin-stimulated ductal secretion of BDL rats by activation of apoptosis through increased expression of Ca2+- dependent PKC isoforms. 133
Selective inhibition of ion transport mechanisms regulating intracellular pH reduces proliferation and induces apoptosis in cholangiocarcinoma cells. 132
EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis 131
Gastrointestinal Complications after Allogeneic Hematopoietic Stem Cell Transplant: A Multidisciplinary Approach with Early Endoscopic Evaluation 131
Angiogenic factors in chronic liver diseases: the effects on hepatic progenitor cells 130
Cancer-Associated Fibroblasts in Cholangiocarcinoma: Current Knowledge and Possible Implications for Therapy 129
Semaphorin 7A contributes to TGF-β-mediated liver fibrogenesis 128
Targeting UBC9-mediated protein hyper-SUMOylation in cystic cholangiocytes halts polycystic liver disease in experimental models 128
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease. 127
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 127
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies. 126
The Impact of Radiofrequency Ablation on Survival Outcomes and Stent Patency in Patients with Unresectable Cholangiocarcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 125
Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production. 125
Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis 125
Bile Acids in Polycystic Liver Diseases: Triggers of Disease Progression and Potential Solution for Treatment 125
Selective Na+/H+ inhibition by cariporide reduces liver fibrosis in the rat 123
Autocrine/paracrine regulation of the growth of the biliary tree by the neuroendocrine hormone serotonin 123
Locally acquired hepatitis E virus in Marche Italy: Clinical/laboratory features and outcome 123
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 122
Follow-up magnetic resonance imaging/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret 122
Involvement of autophagy in ageing and chronic cholestatic diseases 122
Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis 121
Taurohyodeoxycholate- and tauroursodeoxycholate-induced hypercholeresis is augmented in bile duct ligated rats 120
Glucagon-like Peptide-1 and its receptor agonist exendin-4 modulate cholangiocyte adaptive response to cholestasis 120
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 120
Taurocholic acid feeding prevents tumor necrosis factor-alpha-induced damage of cholangiocytes by a PI3K-mediated pathway. 119
Secretin stimulates biliary cell proliferation by regulating expression of microRNA 125b and microRNA let7a in mice 119
Cariporide a selective Na+ /H+ exchange inhibitor, reduces PDGF-induced proliferation and oxidative stress product formation in rat hepatic stellate cells (HSC). 119
Autocrine Regulation of Biliary Pathology by Activated Cholangiocytes. 118
Role of cholangiocytes in primary biliary cirrhosis 118
Mouse models of liver fibrosis mimic human liver fibrosis of different etiologies 118
Serum micrornas as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma 118
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference 118
Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach 118
Risk Stratification in Primary Biliary Cholangitis 117
Role of apoptosis in development of primary biliary cirrhosis 115
Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma 115
Effects of Vedolizumab in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases 115
Selective Na+/H+ exchange inhibition by cariporide reduces liver fibrosis in the rat. 114
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis 114
The management of cholestatic liver diseases: Current therapies and emerging new possibilities 113
Patients with Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease Diagnosis 112
Functional heterogeneity of the intrahepatic biliary tree 111
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 111
Hepatic, gastric and bone marrow AL amyloidosis that began with Budd-Chiari syndrome: a case report 110
Cholangiocyte injury and ductopenic syndromes. 110
Totale 14.039
Salva come PNG Salva come JPEG
Categoria #
all - tutte 109.183
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.183
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022939 0 0 19 36 14 68 79 83 67 98 219 256
2022/20232.495 212 202 140 188 154 616 4 160 600 13 159 47
2023/20241.519 246 33 118 302 241 326 16 29 11 27 10 160
2024/20252.771 317 277 103 45 82 115 159 96 702 206 282 387
2025/20268.578 501 450 695 1.099 840 573 1.451 828 723 740 287 391
2026/20271.106 566 352 188 0 0 0 0 0 0 0 0 0
Totale 22.272